Steven Pipe's guest appearances

Steven Pipe

BloodStream

Ask The Expert - A BloodStream Media Podcast

Chris Bombardier

Debbie de la Riva

Robert Sidonio

Jorge de la Riva

Sharon Meyers

Rich Pezzillo

Len Valentino

Guy Young

Justin Levesque

Miriam Goldstein

Damian Washington

James Hunt

Michael Callaghan

Dana Francis

Jeremy Griffin

OwlTail

We’ve got Dr. Steven Pipe with us to discuss the first gene therapy approved for hemophilia B, HEMGENIX. As the lead investigator of the HEMGENIX trial, Dr. Pipe details what patients need to know about HEMGENIX and what questions to consider when speaking with their hematologist. A must listen episode!    Show Notes: Subscribe:  The BloodStream Podcast Presenting Sponsor: Takeda, visit bleedingdisorders.com to learn more.   Connect with BloodStream Media: BloodStreamMedia.com BloodStream on Facebook  BloodStream on Twitter

We’ve got Dr. Steven Pipe with us to discuss the first gene therapy approved for hemophilia B, HEMGENIX. As the lead investigator of the HEMGENIX trial, Dr. Pipe details what patients need to know about HEMGENIX and what questions to consider when speaking with their hematologist. A must listen episode!  Show Notes: Subscribe: <a href="https://podcasts.apple.com/us/podcast/bloodstream/id1133574474" rel="nofollow" target="_blank"> The BloodStream Podcast</a> Presenting Sponsor: Takeda, visit <a href="http://bleedingdisorders.com/" rel="nofollow" target="_blank">bleedingdisorders.com</a> to learn more. Connect with BloodStream Media: <a href="https://www.bloodstreammedia.com/" rel="nofollow" target="_blank">BloodStreamMedia.com</a> <a href="http://www.facebook.com/BloodStreamMedia" rel="nofollow" target="_blank">BloodStream on Facebook</a> <a href="https://twitter.com/BloodStreamInfo" rel="nofollow" target="_blank">BloodStream on Twitter</a>

Dr. Steven Pipe on HEMGENIX, hemophilia B’s first gene therapy

In this episode, Dr. Steven Pipe, a pediatric hematologist out of the University of Michigan who is also the chair of the National Hemophilia Foundation’s Medical and Scientific Advisory Council (MASAC) discusses the major takeaways from the International Society of Thrombosis and Hemostasis’ (ISTH) 2017 Congress, which took place this July in Berlin, Germany. Dr. Pipe shares the latest updates on non-factor replacement therapies, gene therapy, and more on Episode 5 of BloodStream Media’s Ask The Expert podcast series! Disclaimer: The content contained within Ask The Expert is for informational purposes only. Please consult your healthcare provider before making any decisions about treatment. Have a bleeding disorders-related question you’d like to submit to Ask The Expert? Excellent! You can email it to mailbag@bloodstreammedia.com (Subject: Ask The Expert Question), post it on the wall of our Facebook Page, Facebook.com/BloodStreamMedia or tweet it to us @BloodStreamInfo or @pjlynch (host)   ISTH Congress 2017 Headlines: BioMarin and Spark:  http://www.biopharmadive.com/news/hemophilia-ISTH-spark-alnylam-gene-therapy-biomarin/446849/ Idelvion:  https://hemophilianewstoday.com/2017/07/14/hemophilia-b-pediatric-adult-patients-benefit-from-idelvion-studies-show/ Emicizumab:  https://www.dddmag.com/article/2017/07/positive-results-emicizumab-phase-iii-studies-hemophilia-inhibitors Nuwiq:  http://www.businesswire.com/news/home/20170709005080/en/ISTH-2017-Berlin-Octapharma-presents-exciting-Nuwiq%C2%AE Q&amp;A with R&amp;D chief of Bioverativ:  https://www.dddmag.com/article/2017/07/bioverativ-r-d-chief-breaks-down-data-blood-disorder-drug-pipeline Steven Pipe presents small molecule therapies:  http://isthcongressdaily.org/novel-therapies-hemophilia-small-molecules-treatment-hemophilia/

In this episode, Dr. Steven Pipe, a pediatric hematologist out of the University of Michigan who is also the chair of the National Hemophilia Foundation’s Medical and Scientific Advisory Council (MASAC) discusses the major takeaways from the International Society of Thrombosis and Hemostasis’ (ISTH) 2017 Congress, which took place this July in Berlin, Germany. Dr. Pipe shares the latest updates on non-factor replacement therapies, gene therapy, and more on Episode 5 of BloodStream Media’s Ask The Expert podcast series! Disclaimer: The content contained within Ask The Expert is for informational purposes only. Please consult your healthcare provider before making any decisions about treatment. Have a bleeding disorders-related question you’d like to submit to Ask The Expert? Excellent! You can email it to mailbag@bloodstreammedia.com (Subject: Ask The Expert Question), post it on the wall of our Facebook Page, <a href="http://facebook.com/BloodStreamMedia" rel="nofollow" target="_blank">Facebook.com/BloodStreamMedia</a> or tweet it to us <a href="https://twitter.com/BloodStreamInfo" rel="nofollow" target="_blank">@BloodStreamInfo</a> or <a href="https://twitter.com/pjlynch" rel="nofollow" target="_blank">@pjlynch</a> (host) ISTH Congress 2017 Headlines: BioMarin and Spark: <a href="http://www.biopharmadive.com/news/hemophilia-ISTH-spark-alnylam-gene-therapy-biomarin/446849/" rel="nofollow" target="_blank"> http://www.biopharmadive.com/news/hemophilia-ISTH-spark-alnylam-gene-therapy-biomarin/446849/</a> Idelvion: <a href="https://hemophilianewstoday.com/2017/07/14/hemophilia-b-pediatric-adult-patients-benefit-from-idelvion-studies-show/" rel="nofollow" target="_blank"> https://hemophilianewstoday.com/2017/07/14/hemophilia-b-pediatric-adult-patients-benefit-from-idelvion-studies-show/</a> Emicizumab: <a href="https://www.dddmag.com/article/2017/07/positive-results-emicizumab-phase-iii-studies-hemophilia-inhibitors" rel="nofollow" target="_blank"> https://www.dddmag.com/article/2017/07/positive-results-emicizumab-phase-iii-studies-hemophilia-inhibitors</a> Nuwiq: <a href="http://www.businesswire.com/news/home/20170709005080/en/ISTH-2017-Berlin-Octapharma-presents-exciting-Nuwiq%C2%AE" rel="nofollow" target="_blank"> http://www.businesswire.com/news/home/20170709005080/en/ISTH-2017-Berlin-Octapharma-presents-exciting-Nuwiq%C2%AE</a> Q&amp;A with R&amp;D chief of Bioverativ: <a href="https://www.dddmag.com/article/2017/07/bioverativ-r-d-chief-breaks-down-data-blood-disorder-drug-pipeline" rel="nofollow" target="_blank"> https://www.dddmag.com/article/2017/07/bioverativ-r-d-chief-breaks-down-data-blood-disorder-drug-pipeline</a> Steven Pipe presents small molecule therapies: <a href="http://isthcongressdaily.org/novel-therapies-hemophilia-small-molecules-treatment-hemophilia/" rel="nofollow" target="_blank"> http://isthcongressdaily.org/novel-therapies-hemophilia-small-molecules-treatment-hemophilia/</a>

Ep. 5: ISTH Recap - w/ Dr. Steven Pipe - July 24, 2017

On this episode, Dr. Steven Pipe- pediatric hematologist and Chair of the National Hemophilia Foundation’s (NHF) Medical and Scientific Advisory Council- provides an update on new and developing treatment products immediately following his attending the International Society on Thrombosis and Hemostasis (ISTH) Congress. Natalie leads a discussion on a recent CDC study that indicates opioid prescriptions are on the decline, Patrick initiates a game based on a new bleeding disorders online platform, and a community member shares her take on platelet disorders. All this and more on Episode 14 of The BloodStream Podcast!  Opioid Prescriptions Fall After 2010 Peak, C.D.C Report Finds  https://www.nytimes.com/2017/07/06/health/opioid-painkillers-prescriptions-united-states.html Rare Platlet Disorders:  https://stepsforliving.hemophilia.org/basics-of-bleeding-disorders/types-of-bleeding-disorders/rare-platelet-disorders ISTH Congress 2017 Headlines:  BioMarin and Spark: http://www.biopharmadive.com/news/hemophilia-ISTH-spark-alnylam-gene-therapy-biomarin/446849/    Idelvion: https://hemophilianewstoday.com/2017/07/14/hemophilia-b-pediatric-adult-patients-benefit-from-idelvion-studies-show/    Emicizumab: https://www.dddmag.com/article/2017/07/positive-results-emicizumab-phase-iii-studies-hemophilia-inhibitors   Nuwiq: http://www.businesswire.com/news/home/20170709005080/en/ISTH-2017-Berlin-Octapharma-presents-exciting-Nuwiq%C2%AE   Q&amp;A with R&amp;D chief of Bioverativ: https://www.dddmag.com/article/2017/07/bioverativ-r-d-chief-breaks-down-data-blood-disorder-drug-pipeline   Steven Pipe presents small molecule therapies: http://isthcongressdaily.org/novel-therapies-hemophilia-small-molecules-treatment-hemophilia/   BloodFeed: https://www.bloodfeed.com Powering Through Podcast http://poweringthrough.org/podcast Ask The Expert Podcast http://bloodstreamexpert.com

On this episode, Dr. Steven Pipe- pediatric hematologist and Chair of the National Hemophilia Foundation’s (NHF) Medical and Scientific Advisory Council- provides an update on new and developing treatment products immediately following his attending the International Society on Thrombosis and Hemostasis (ISTH) Congress. Natalie leads a discussion on a recent CDC study that indicates opioid prescriptions are on the decline, Patrick initiates a game based on a new bleeding disorders online platform, and a community member shares her take on platelet disorders. All this and more on Episode 14 of The BloodStream Podcast!  Opioid Prescriptions Fall After 2010 Peak, C.D.C Report Finds <a href="https://www.nytimes.com/2017/07/06/health/opioid-painkillers-prescriptions-united-states.html" rel="nofollow" target="_blank"> https://www.nytimes.com/2017/07/06/health/opioid-painkillers-prescriptions-united-states.html</a> Rare Platlet Disorders: <a href="https://stepsforliving.hemophilia.org/basics-of-bleeding-disorders/types-of-bleeding-disorders/rare-platelet-disorders" rel="nofollow" target="_blank"> https://stepsforliving.hemophilia.org/basics-of-bleeding-disorders/types-of-bleeding-disorders/rare-platelet-disorders</a> ISTH Congress 2017 Headlines: BioMarin and Spark: <a href="http://www.biopharmadive.com/news/hemophilia-ISTH-spark-alnylam-gene-therapy-biomarin/446849/" rel="noopener nofollow" target="_blank">http://www.biopharmadive.com/news/hemophilia-ISTH-spark-alnylam-gene-therapy-biomarin/446849/</a>    Idelvion: <a href="https://hemophilianewstoday.com/2017/07/14/hemophilia-b-pediatric-adult-patients-benefit-from-idelvion-studies-show/" rel="noopener nofollow" target="_blank">https://hemophilianewstoday.com/2017/07/14/hemophilia-b-pediatric-adult-patients-benefit-from-idelvion-studies-show/</a>   Emicizumab: <a href="https://www.dddmag.com/article/2017/07/positive-results-emicizumab-phase-iii-studies-hemophilia-inhibitors" rel="noopener nofollow" target="_blank">https://www.dddmag.com/article/2017/07/positive-results-emicizumab-phase-iii-studies-hemophilia-inhibitors</a>   Nuwiq: <a href="http://www.businesswire.com/news/home/20170709005080/en/ISTH-2017-Berlin-Octapharma-presents-exciting-Nuwiq%C2%AE" rel="noopener nofollow" target="_blank">http://www.businesswire.com/news/home/20170709005080/en/ISTH-2017-Berlin-Octapharma-presents-exciting-Nuwiq%C2%AE</a> Q&amp;A with R&amp;D chief of Bioverativ: <a href="https://www.dddmag.com/article/2017/07/bioverativ-r-d-chief-breaks-down-data-blood-disorder-drug-pipeline" rel="noopener nofollow" target="_blank">https://www.dddmag.com/article/2017/07/bioverativ-r-d-chief-breaks-down-data-blood-disorder-drug-pipeline</a>   Steven Pipe presents small molecule therapies: <a href="http://isthcongressdaily.org/novel-therapies-hemophilia-small-molecules-treatment-hemophilia/" rel="noopener nofollow" target="_blank">http://isthcongressdaily.org/novel-therapies-hemophilia-small-molecules-treatment-hemophilia/</a> BloodFeed: <a href="https://www.bloodfeed.com" rel="nofollow" target="_blank">https://www.bloodfeed.com</a> Powering Through Podcast <a href="http://poweringthrough.org/podcast" rel="nofollow" target="_blank">http://poweringthrough.org/podcast</a> Ask The Expert Podcast <a href="http://bloodstreamexpert.com" rel="nofollow" target="_blank">http://bloodstreamexpert.com</a>